Ayurcann terminates SPAC deal, citing regulatory filing failures
Arogo also initiated its own claim that the deal had been terminated, demanding the same $250,000 fee.
The post Ayurcann terminates SPAC deal, citing regulatory filing failures appeared first on Green Market Report.